background image

Clinical Trials In Connecticut

Discover hundreds of clinical trials in Connecticut.
Search clinical trials in Connecticut by city, condition or phase.

e.g. Respiratory Diseases
ConnecticutHealthy volunteers: No

A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome

Recruiting
PHASE3

Sponsor:

Janssen Research & Development, LLC

Location:

Danbury, Poughkeepsie, Stamford, Valhallashow 147 more

Code:

NCT05754957

Conditions

Acute Coronary Syndrome

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Milvexian

Placebo

A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma

Recruiting
PHASE3

Sponsor:

National Cancer Institute (NCI)

Location:

New Haven, Hartford, Valhalla, New Hyde Parkshow 99 more

Code:

NCT03871257

Conditions

Low Grade Glioma

Neurofibromatosis Type 1

Visual Pathway Glioma

Eligibility Criteria

Sex: All

Age: 2 - 21

Healthy Volunteers: Not accepted

Interventions

Carboplatin

Magnetic Resonance Imaging

Quality-of-Life Assessment

Questionnaire Administration

Selumetinib Sulfate

Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)

Recruiting

Sponsor:

Novartis Pharmaceuticals

Location:

Farmington, New Haven, Stony Brook, Morristownshow 44 more

Code:

NCT04174157

Conditions

Spinal Muscular Atrophy (SMA)

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Prospective observational registry

Zolgensma

A Trial to Find Out if REGN5678 is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors

Recruiting
PHASE1
PHASE2

Sponsor:

Regeneron Pharmaceuticals

Location:

New Haven, New York, Providence, Bostonshow 8 more

Code:

NCT03972657

Conditions

Metastatic Castration-resistant Prostate Cancer (mCRPC)

Clear Cell Renal Cell Carcinoma (ccRCC)

Eligibility Criteria

Sex: Male

Age: 18+

Healthy Volunteers: Not accepted

Interventions

REGN5678

Cemiplimab

Evaluation of Topical ATR12-351 in Adults With Netherton Syndrome

Recruiting
PHASE1

Sponsor:

Azitra Inc.

Location:

New Haven

Code:

NCT06137157

Conditions

Netherton Syndrome

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

ATR12-351

AGN-193408 SR in the Treatment of Open-angle Glaucoma or Ocular Hypertension

Recruiting
PHASE1
PHASE2

Sponsor:

AbbVie

Location:

Danbury, Newark, South Orange, Bostonshow 27 more

Code:

NCT04499248

Conditions

Open-angle Glaucoma

Ocular Hypertension

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

AGN-193408 SR

Lumigan

Sham Administration

Lumigan Vehicle

A Trial to Determine Weight Gain Benefits of Caloric Supplementation for NAS Infants

Recruiting

Sponsor:

Yale University

Location:

New Haven

Code:

NCT04419857

Conditions

Neonatal Abstinence Syndrome

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

High-calorie formula

Blood Pressure Variability and Ischemic Stroke Outcome

Recruiting

Sponsor:

Yale University

Location:

New Haven, Boston, Chicago

Code:

NCT05756257

Conditions

Acute Ischemic Stroke

Blood Pressure Variability

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Comparison of Two- Versus Three-antibiotic Therapy for Pulmonary Mycobacterium Avium Complex Disease

Recruiting
PHASE2
PHASE3

Sponsor:

Kevin Winthrop

Location:

New Haven, Manhasset, New York, Philadelphiashow 23 more

Code:

NCT03672630

Conditions

Mycobacterium Avium Complex

Nontuberculous Mycobacterium Infection

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Azithromycin

Ethambutol

Rifampin

A Study of GV20-0251 Monotherapy and GV20-0251 in Combination with Pembrolizumab in Participants with Solid Tumor Malignancies

Recruiting
PHASE1
PHASE2

Sponsor:

GV20 Therapeutics

Location:

New Haven, New York, Boston, Fairfaxshow 8 more

Code:

NCT05669430

Conditions

Solid Tumor, Adult

Refractory Cancer

Endometrial Carcinoma (EC)

Squamous Head and Neck Carcinoma

PMMR/MSS Adenocarcinoma of the Colon or Rectum

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

GV20-0251

GV20-0251 and Pembrolizumab [KEYTRUDA®]

Connecticut stands out as a prime location for a wide variety of clinical trials, largely thanks to its robust healthcare system and renowned medical research institutions. Leading centers like Yale School of Medicine, UConn Health, and Jackson Laboratory for Genomic Medicine are at the forefront of groundbreaking studies in the state.

Combining a strong focus on innovation and precision medicine makes Connecticut an ideal destination for participants seeking advanced medical treatments and the opportunity to contribute to cutting-edge research.

Why choose Connecticut for clinical trials?

Common conditions studied in Connecticut

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Connecticut